To assess the potential of sprifermin as a disease-modifying osteoarthritis agent, authors of the FORWARD randomized clinical trial evaluated the agent’s impact on femorotibial joint cartilage thickness...
To assess the potential of sprifermin as a disease-modifying osteoarthritis agent, authors of the FORWARD randomized clinical trial evaluated the agent’s impact on femorotibial joint cartilage thickness...
Therapeutic options for hand osteoarthritis are limited. The authors of a new study presented at the Annual European Congress of Rheumatology investigated the efficacy and safety of short-term, low-dose...
Researchers tracked changes in bone mineral density and vertebral fractures among more than 800 women with osteoarthritis and osteoporosis enrolled in the Abaloparatide Comparator Trial In Vertebral...
Researchers evaluated data on more than 358,100 individuals with osteoarthritis undergoing total joint replacement to determine how geography and health care access influences long‐term opioid use.
Researchers analyzed data on more than 4700 postmenopausal women to evaluate the controversial relationship between knee osteoarthritis and menopausal hormone therapy.
In an attempt to predict 40-year knee osteoarthritis risk in adolescents, researchers simplified a previously published knee OA risk prediction model. The efficacy of the model was tested in a new study. ...
In an attempt to predict 40-year knee osteoarthritis risk in adolescents, researchers simplified a previously published knee OA risk prediction model. The efficacy of the model was tested in a new study. ...
Previous research has indicated that OA is an independent risk factor for CVD, but the relationship is complicated, due to the frequent use of NSAIDs in OA.
In a recent study, researchers sought to evaluate rates of hyaluronic acid and corticosteroid injection receipt in patients with knee osteoarthritis and determine the impact of updated clinical guidelines...
